These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33117085)

  • 1. Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMT.
    Zhang R; Wang Z; You W; Zhou F; Guo Z; Qian K; Xiao Y; Wang X
    Cancer Cell Int; 2020; 20():520. PubMed ID: 33117085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paeonol inhibits proliferation and induces cell apoptosis of human T24 and 5637 bladder cancer cells in vitro and in vivo.
    Zhang JJ; Cai LJ; Pang K; Dong Y; Zhang ZG; Li BB; Li R; Han CH
    Clin Transl Oncol; 2021 Mar; 23(3):601-611. PubMed ID: 32691366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
    Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway.
    Zhang C; Chang X; Chen D; Yang F; Li Z; Li D; Yu N; Yan L; Liu H; Xu Z
    Cancer Manag Res; 2019; 11():7909-7923. PubMed ID: 31692549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells.
    Lin W; Xie J; Xu N; Huang L; Xu A; Li H; Li C; Gao Y; Watanabe M; Liu C; Huang P
    Int J Biol Sci; 2018; 14(4):418-426. PubMed ID: 29725263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro.
    Smolensky D; Rathore K; Cekanova M
    BMC Cancer; 2015 Nov; 15():927. PubMed ID: 26597249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSPAN7 Exerts Anti-Tumor Effects in Bladder Cancer Through the PTEN/PI3K/AKT Pathway.
    Yu X; Li S; Pang M; Du Y; Xu T; Bai T; Yang K; Hu J; Zhu S; Wang L; Liu X
    Front Oncol; 2020; 10():613869. PubMed ID: 33489923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
    Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
    Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plumbagin inhibits proliferation and induces apoptosis of hepatocellular carcinoma by downregulating the expression of SIVA.
    Li T; Lv M; Chen X; Yu Y; Zang G; Tang Z
    Drug Des Devel Ther; 2019; 13():1289-1300. PubMed ID: 31118568
    [No Abstract]   [Full Text] [Related]  

  • 10. RAC3 Inhibition Induces Autophagy to Impair Metastasis in Bladder Cancer Cells
    Wang L; Shi J; Liu S; Huang Y; Ding H; Zhao B; Liu Y; Wang W; Yang J; Chen Z
    Front Oncol; 2022; 12():915240. PubMed ID: 35847878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway.
    Wang F; Mao Y; You Q; Hua D; Cai D
    Int J Immunopathol Pharmacol; 2015 Sep; 28(3):362-73. PubMed ID: 26246196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plumbagin inhibits cell proliferation and promotes apoptosis in multiple myeloma cells through inhibition of the PI3K/Akt-mTOR pathway.
    Wu H; Dai X; Wang E
    Oncol Lett; 2016 Nov; 12(5):3614-3618. PubMed ID: 27900044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jagged2 progressively increased expression from Stage I to III of Bladder Cancer and Melatonin-mediated downregulation of Notch/Jagged2 suppresses the Bladder Tumorigenesis
    Chen YT; Huang CR; Chang CL; Chiang JY; Luo CW; Chen HH; Yip HK
    Int J Biol Sci; 2020; 16(14):2648-2662. PubMed ID: 32792862
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer.
    Kumar S; Agnihotri N
    Biomed Pharmacother; 2019 Jan; 109():1462-1477. PubMed ID: 30551398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway.
    Zhang X; Liu Z; Chen S; Li H; Dong L; Fu X
    J Ethnopharmacol; 2022 Jan; 283():114742. PubMed ID: 34655668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ID2 Inhibits Bladder Cancer Progression and Metastasis
    Mao W; Wang K; Sun S; Wu J; Chen M; Geng J; Luo M
    Front Cell Dev Biol; 2021; 9():738364. PubMed ID: 34746132
    [No Abstract]   [Full Text] [Related]  

  • 19. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
    Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
    Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
    Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
    Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.